Department of Emergency, Ningbo First Hospital, Ningbo, Zhejiang Province, China.
JBI Evid Implement. 2023 Sep 1;21(3):269-276. doi: 10.1097/XEB.0000000000000365.
To explore the practice and effect evaluation of the early restrictive fluid resuscitation strategy in the nursing care of patients with sepsis in the emergency department.
A total of 239 sepsis patients, who were treated in the emergency department of our hospital from January to September 2020, were selected as the participants of this study, and a retrospective analysis was performed. According to different methods of fluid resuscitation, they were divided into an improved group and a control group. One hundred and twelve patients who received restrictive fluid resuscitation were in the improved group; another 127 patients who received adequate fluid resuscitation were in the control group. The ICU stay time, ventilator use time, and 28-day mortality rate of the two groups were observed. The hemodynamic indices, acute physiology and chronic health evaluation (APACHE) II score, sequential organ failure assessment (SOFA) score, and complications of the two groups before and after treatment were compared.
After treatment, in the improved group, the APACHE II and SOFA scores were lower than in the control group, fluid replacement decreased, lactate clearance increased, ICU admission time shortened and the proportion of ventilator time to ICU admission time decreased. The incidence of acute respiratory distress syndrome (ARDS), cTn I and brain natriuretic peptic in the improved group were significantly lower than those in the control group. From the dimension within the group, the APACHE II score, SOFA score, heart rate and shock index were lower after treatment than before treatment in both the improved and control groups.
Restricted fluid resuscitation can effectively alleviate the condition of emergency sepsis patients, improve hemodynamics, reduce the incidence of ARDS, and prevent patient deaths. It is worthy of clinical application.
探讨早期限制性液体复苏策略在急诊科脓毒症患者护理中的应用实践及效果评价。
选取 2020 年 1 月至 9 月在我院急诊科治疗的 239 例脓毒症患者为研究对象,进行回顾性分析。根据液体复苏方式的不同分为改良组和对照组,其中接受限制性液体复苏的 112 例患者为改良组,接受充分液体复苏的 127 例患者为对照组。观察两组患者的 ICU 入住时间、呼吸机使用时间和 28 天病死率。比较两组患者治疗前后的血流动力学指标、急性生理学与慢性健康状况评分系统(APACHE)Ⅱ评分、序贯器官衰竭评估(SOFA)评分及并发症发生情况。
治疗后,改良组患者的 APACHEⅡ和 SOFA 评分低于对照组,液体置换量减少,乳酸清除率增加,ICU 入住时间缩短,呼吸机使用时间与 ICU 入住时间的比例降低,急性呼吸窘迫综合征(ARDS)、肌钙蛋白 I(cTn I)和脑钠肽(BNP)发生率低于对照组。组内比较,改良组和对照组治疗后 APACHEⅡ评分、SOFA 评分、心率和休克指数均低于治疗前。
限制性液体复苏可有效改善急诊脓毒症患者的病情,改善血流动力学,降低 ARDS 发生率,降低病死率,值得临床推广应用。